Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Requirement for Post-Operative Pain Control in Elective 1-3 Level Transforaminal Lumbar Interbody Fusion: Comparison of Thoracolumbar Interfascial Plane Block With Exparel to Bupivacaine HCl

NCT06350981 is registered in ClinicalTrials.gov with Foundation for Orthopaedic Research and Education as lead sponsor.

NCT NCT06350981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06350981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Requirement for Post-Operative Pain Control in Elective 1-3 Level Transforaminal Lumbar Interbody Fusion: Comparison of Thoracolumbar Interfascial Plane Block With Exparel to Bupivacaine HCl
Lead sponsor
Foundation for Orthopaedic Research and Education
Phase
Phase 2/3
Overall status
Enrolling by invitation
Start date
April 30, 2024
Completion date
March 1, 2027
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, narcotic use, physical stress, post operative pain, surgery-complications